From October 1, 2023 to November 17, 2023, the company has repurchased 6,106,800 shares, representing 0.54% for CNY 100.02 million. With this, the company has completed the repurchase of 9,015,780 shares, representing 0.8% for CNY 150 million under the buyback announced on September 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.61 CNY | -2.14% | -1.48% | -3.50% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.50% | 2.41B | |
+38.69% | 728B | |
+33.08% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+15.80% | 244B | |
+7.81% | 207B | |
-5.36% | 205B | |
+6.42% | 164B |
- Stock Market
- Equities
- 000623 Stock
- News Jilin Aodong Pharmaceutical Group Co., Ltd.
- Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.